韩国晚期或复发性子宫内膜癌的疾病负担和治疗模式:全国数据库 (DIRECTION) 研究
Hyun-Woong Cho1, Se Ik Kim2, Min-Ji Bae3
1Department of Obstetrics and Gynecology, Korea University Guro Hospital, Seoul, Korea.
Cancer research and treatment
|October 24, 2025
概括
在晚期/复发性子宫内膜癌 (EC) 中,全身抗癌疗法 (SACT) 模式显示治疗间隔缩短,医疗负担增加. 这凸显了对晚期/复发性结核病患者更有效的治疗方法的需求.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 卫生经济学 卫生经济学
背景情况:
- 晚期/复发的子宫内膜癌 (EC) 与早期疾病相比,预后不好.
- 现实世界疾病负担,包括治疗模式和医疗利用,对于高级/复发性EC仍然不完全理解.
研究的目的:
- 研究全身抗癌疗法 (SACT) 的模式.
- 分析医疗保健资源利用率 (HCRU) 和相关成本.
- 了解晚期/复发性EC患者的预后.
主要方法:
- 一项基于全国人口的研究,利用2008年至2022年的韩国索赔数据.
- 包括接受一线SACT的高级/复发性EC的成年患者.
- 对SACT模式,预后,全因和EC相关的HCRU以及成本的分析.
主要成果:
- 基于的疗法是最常见的SACT.
- 中位数无SACT间隔和下一次治疗的时间 (TTNT) 在治疗线上显示下降趋势.
- 所有原因和EC相关的HCRU和成本随着SACT的进展而增加,总成本显著上升PPPM.
结论:
- 在SACT治疗方案测序中存在显著的变异性,这表明对于复发性EC缺乏治疗共识.
- 减少TTNT和SACT无间隔,以及增加HCRU和成本,意味着预后恶化和疾病负担增加.
- 迫切需要新型治疗药物和更有效的治疗方法,以解决高级/复发性EC未满足的临床需求.
更多相关视频
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
13.0K
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.5K
相关概念视频
Disorders of the Female Reproductive System
3.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.8K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
